SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-118824
Filing Date
2011-04-29
Accepted
2011-04-29 17:03:47
Documents
4
Period of Report
2011-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21001
2 PRESS RELEASE dex991.htm EX-99.1 67892
3 GRAPHIC g179690g28g69.jpg GRAPHIC 5090
4 GRAPHIC g179690g62a97.jpg GRAPHIC 3400
  Complete submission text file 0001193125-11-118824.txt   102055
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 11795829
SIC: 2834 Pharmaceutical Preparations